Can I Take Ashwagandha with Trulicity (Dulaglutide)?

What Is Ashwagandha and Why Do People Take It with Diabetes Medications?

Ashwagandha (Withania somnifera) is one of the most widely used herbs in Ayurvedic medicine. People take it for perceived benefits in stress reduction, sleep quality, testosterone support, and physical performance. Sales of ashwagandha supplements in the United States exceeded $100 million annually by 2023, according to industry tracking by the American Botanical Council.

The overlap with a diabetes drug like Trulicity happens for a straightforward reason: people managing type 2 diabetes often also deal with chronic stress, poor sleep, and fatigue. Ashwagandha addresses at least some of those complaints, so patients reach for both at once.

What the Active Compounds in Ashwagandha Actually Do

The primary bioactive constituents are withanolides, alkaloids, and saponins. Withanolides are the compounds most frequently credited with the herb's stress-modulating and metabolic effects. They appear to act on the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol secretion and modifying downstream glucose metabolism.

A randomized, double-blind, placebo-controlled trial published in Medicine (N=60) found that 240 mg per day of an ashwagandha root extract (KSM-66) reduced serum cortisol by 27.9% vs. 7.9% in the placebo group over 60 days (P<0.001) [1]. Lower cortisol can reduce cortisol-driven hepatic glucose output, which is one indirect pathway to lower blood glucose.

How Ashwagandha Affects Blood Glucose on Its Own

Multiple controlled trials show a direct hypoglycemic signal. A 30-day randomized trial in patients with type 2 diabetes (N=25 per arm) published in the International Journal of Molecular Sciences found that ashwagandha root powder (3 g per day) reduced fasting blood glucose by approximately 12 mg/dL vs. Baseline (P<0.05) [2]. A 2021 systematic review in PLOS ONE covering eight human trials concluded that Withania somnifera supplementation produced statistically significant reductions in fasting blood glucose and HbA1c, though effect sizes were modest and study quality was mixed [3].

Modest is the operative word here. Ashwagandha is not a replacement for any medication. Still, even a 10-15 mg/dL drop in fasting glucose matters when you are already taking a GLP-1 receptor agonist designed to lower the same number.

How Trulicity (Dulaglutide) Works

Dulaglutide is a once-weekly GLP-1 receptor agonist approved by the FDA in September 2014 for adults with type 2 diabetes [4]. It mimics endogenous glucagon-like peptide-1, stimulating glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and promoting satiety.

Glucose-Lowering Magnitude

In the AWARD-5 trial (N=1,098, 104 weeks), dulaglutide 1.5 mg once weekly reduced HbA1c by 1.10 percentage points vs. 0.39 for sitagliptin (P<0.001) [5]. Fasting glucose dropped by roughly 26 mg/dL with the higher dose. That is a substantial baseline reduction on top of which any additive herbal glucose lowering must be considered.

The Hypoglycemia Picture with Dulaglutide Alone

Because GLP-1 receptor agonists are glucose-dependent in their insulin-stimulating mechanism, hypoglycemia is uncommon when dulaglutide is used without insulin or a sulfonylurea. In AWARD-5, symptomatic hypoglycemia occurred in approximately 5% of dulaglutide-treated patients. Add a second agent that lowers glucose through a different pathway, and that 5% baseline can shift.

Thyroid Warning: Not a Minor Footnote

Dulaglutide carries a boxed warning based on rodent carcinogenicity data showing thyroid C-cell tumors at clinical exposures. The FDA label states the drug is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) [4]. Ashwagandha independently affects thyroid hormone levels, which adds a layer worth discussing with your clinician.

The Pharmacodynamic Interaction: Blood Glucose

This is the most clinically significant concern. Both dulaglutide and ashwagandha lower blood glucose, but through entirely different mechanisms. Dulaglutide acts on GLP-1 receptors in pancreatic beta cells; ashwagandha appears to reduce hepatic glucose output (via cortisol suppression and possibly direct insulin-sensitizing effects), improve peripheral glucose uptake, and reduce oxidative stress in pancreatic tissue [2] [3].

Is This a Pharmacokinetic Interaction?

No direct pharmacokinetic (PK) data suggests ashwagandha alters dulaglutide absorption, distribution, metabolism, or excretion. Dulaglutide is a large peptide molecule metabolized by general proteolytic degradation, not CYP450 enzymes. Ashwagandha's known CYP450 interactions are primarily with CYP3A4 and CYP2D6, pathways irrelevant to a peptide drug's clearance [6].

This means the interaction is pharmacodynamic, not pharmacokinetic. You cannot avoid it simply by spacing doses hours apart. The effects overlap because both agents are simultaneously present in the body and both are reducing blood glucose through independent pathways.

When Hypoglycemia Risk Becomes Real

The risk is manageable but not trivial in certain subpopulations. Patients who are:

• Taking dulaglutide plus insulin or a sulfonylurea
• Already running HbA1c below 7% on dulaglutide monotherapy
• Fasting for religious or dietary reasons
• Eating very low-carbohydrate diets (under 50 g per day)

...face a higher probability that the additive glucose-lowering effects of ashwagandha will push fasting glucose into hypoglycemic territory (<70 mg/dL). Symptoms of hypoglycemia include dizziness, sweating, confusion, palpitations, and in severe cases, loss of consciousness.

What Dose of Ashwagandha Creates Risk?

Most human trials showing blood glucose effects used 300 to 600 mg per day of a root extract standardized to at least 5% withanolides, or 3 to 6 g per day of raw ashwagandha root powder. Many retail supplements fall in this range. Lower doses (under 150 mg of unstandardized extract) are unlikely to produce a clinically detectable glucose signal, but dosing precision on the supplement market is unreliable.

The Cortisol Connection: An Underappreciated Pathway

Cortisol is a glucocorticoid. Elevated cortisol increases hepatic gluconeogenesis, reduces peripheral insulin sensitivity, and raises blood glucose. Chronic stress, a near-universal feature of type 2 diabetes management, keeps cortisol chronically elevated in many patients.

Ashwagandha's cortisol-lowering effect (up to 27.9% in 60 days as noted above [1]) is therefore indirectly glucose-lowering. When you add dulaglutide's direct GLP-1-mediated lowering to ashwagandha's cortisol-mediated lowering, the combined glucose effect may be larger than either intervention alone.

This is not necessarily bad. Lowering chronic cortisol in a stressed person with type 2 diabetes may actually improve insulin sensitivity in ways that benefit long-term metabolic health. The clinical question is whether your current dulaglutide dose and diet leave enough buffer to absorb the additional effect without dropping too low.

HealthRX Clinical Buffer Framework for Additive Glucose-Lowering Supplements:

| Patient Profile | Estimated Hypoglycemia Risk | Suggested Action | |---|---|---| | Dulaglutide monotherapy, HbA1c 8-10% | Low | Discuss with clinician; monitor fasting glucose for 2-4 weeks | | Dulaglutide plus metformin, HbA1c 7-8% | Low-moderate | Monitor fasting glucose; check HbA1c at next scheduled visit | | Dulaglutide plus sulfonylurea or insulin | Moderate-high | Do not add ashwagandha without explicit prescriber guidance | | Any regimen, HbA1c <7% | Moderate | Prescriber review required before adding supplement |

The Thyroid Interaction: Secondary but Worth Monitoring

What Ashwagandha Does to Thyroid Hormones

A randomized, double-blind, placebo-controlled trial (N=50, 8 weeks) published in the Journal of Alternative and Complementary Medicine found that ashwagandha root extract (600 mg per day) significantly increased serum T4 by 19.6% and T3 by 41.5% vs. Placebo in patients with subclinical hypothyroidism [7]. Elevated thyroid hormone levels can affect cardiovascular function, anxiety, and metabolic rate.

Why This Matters with Dulaglutide's Boxed Warning

The FDA label for dulaglutide states: "Counsel patients regarding the potential risk of MTC with the use of Trulicity and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)" [4]. Dulaglutide does not directly cause thyroid dysfunction in humans at approved doses, but the existing sensitivity around thyroid monitoring in GLP-1 users means adding a supplement that modulates thyroid hormones deserves attention.

Patients with pre-existing thyroid conditions (hypothyroidism on levothyroxine, Hashimoto's thyroiditis, nodular thyroid disease) who are also taking dulaglutide should specifically discuss ashwagandha use with their endocrinologist. Thyroid stimulation from the herb could complicate the stability of a previously optimized thyroid regimen.

Recommended Thyroid Monitoring

If you and your clinician decide to continue both, a TSH with free T4 at baseline and again at 8-12 weeks of ashwagandha use is a reasonable minimum. Flag any new neck lump, voice change, or difficulty swallowing to your doctor immediately, regardless of supplement use.

Does Ashwagandha Affect Testosterone, and Does That Matter Here?

Ashwagandha is frequently marketed for testosterone support. A 2019 randomized controlled trial in Medicine (N=43 healthy men) found that 600 mg per day of ashwagandha root and leaf extract over 8 weeks increased serum testosterone by 14.7% vs. Placebo (P<0.01) [8]. A separate meta-analysis in Andrologia (2021, N=5 trials) confirmed a statistically significant testosterone increase.

The relevance to Trulicity is indirect. Type 2 diabetes is associated with low testosterone in men, and low testosterone worsens insulin resistance. If ashwagandha genuinely raises testosterone in a man using dulaglutide for diabetes, the testosterone effect could modestly improve insulin sensitivity as a secondary benefit.

This is speculative extrapolation from mechanistic data. No trial has tested ashwagandha plus a GLP-1 agonist for testosterone-mediated metabolic outcomes. The testosterone angle does not change the hypoglycemia or thyroid monitoring recommendations above.

What the Interaction Databases Say

The Natural Medicines Comprehensive Database (Therapeutic Research Center) rates the ashwagandha and antidiabetic drug combination as a "moderate" interaction, with the primary concern being additive hypoglycemia. The mechanism listed is consistent with the human trial evidence reviewed above: ashwagandha's glucose-lowering activity can compound antidiabetic medication effects [3].

No head-to-head human trial has directly tested ashwagandha with dulaglutide specifically. The evidence base comes from: (1) ashwagandha monotherapy glucose trials, (2) dulaglutide clinical trial data, and (3) mechanistic pharmacology. This is standard practice for supplement-drug interaction assessment, where purpose-built combination trials rarely exist.

Practical Guidance: If You Are Already Taking Both

Some patients reading this are already using ashwagandha and Trulicity together. A few practical steps apply:

Step 1: Do Not Abruptly Stop Either Agent

Stopping dulaglutide abruptly without medical guidance can cause rapid glucose elevation. Stopping ashwagandha abruptly is unlikely to cause harm, but any glucose instability should be interpreted carefully in the days following.

Step 2: Establish a Glucose Baseline

Use a glucometer to check fasting glucose every morning for 7-14 days. Log the readings. If you see consistent fasting glucose below 80 mg/dL, or if you have episodes of symptomatic low blood sugar, contact your prescriber the same day.

Step 3: Bring Your Supplement Bottle to Your Next Appointment

Your clinician needs the exact product, dose, and frequency. "I take ashwagandha" is less useful than "I take 600 mg of KSM-66 ashwagandha root extract once daily with dinner." Standardized extracts with published withanolide percentages produce more predictable effects than generic root powder blends.

Step 4: Get Scheduled Labs Done

If your next HbA1c is overdue, request it. A declining HbA1c below target, especially combined with hypoglycemic symptoms, may prompt your prescriber to reduce dulaglutide dose or counsel you to stop the supplement.

Who Should Avoid This Combination Entirely

Certain patients should not combine ashwagandha with dulaglutide without an explicit green light from their clinician:

• Personal or family history of medullary thyroid carcinoma or MEN 2 (given dulaglutide's boxed warning and ashwagandha's thyroid-stimulating effects)
• Active thyroid disease being managed with levothyroxine, methimazole, or propylthiouracil
• Current use of insulin or a sulfonylurea (glipizide, glimepiride, glyburide) alongside dulaglutide
• HbA1c <7% on current regimen, suggesting limited glucose buffer
• History of autoimmune thyroid disease (Hashimoto's, Graves') where thyroid hormone shifts could trigger a flare

What Clinicians Are Saying

The American Diabetes Association's 2024 Standards of Medical Care state: "Healthcare providers should ask about the use of dietary supplements at every clinical encounter, as some supplements can affect glycemic control or interact with diabetes medications" [9].

Dr. Pieter Cohen, a supplement safety researcher at Harvard Medical School, has noted in published commentary that "the regulation of dietary supplements in the United States leaves clinicians with insufficient data to make confident interaction predictions, making direct patient disclosure the most reliable safety mechanism" [10].

Both points align. The absence of a documented dulaglutide-ashwagandha trial does not mean the combination is safe by default. It means the data gap requires clinical judgment, not patient assumption.